• Users Online: 12891
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
JayU Sheth,Raja Narayanan,Giridhar Anantharaman,Muna Bhende,Aniruddha Agarwal,Shobhit Chawla,Anand Rajendran
Indian Journal of Ophthalmology.2022;70(8)3102
[DOI]
2Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
Prashant Jain,Giridhar Anantharaman,Mahesh Gopalakrishnan,Anubhav Goyal
Indian Journal of Ophthalmology.2018;66(8)1119
[DOI]
3Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
Wei Kiong Ngo,Wai Kitt Chee,Colin S. Tan,Tock Han Lim
BMC Ophthalmology.2020;20(1)1119
[DOI]
4Polypoidal Choroidal Vasculopathy: An Update on Diagnosis and Treatment
Parveen Sen,George Manayath,Daraius Shroff,Vineeth Salloju,Priyanka Dhar
Clinical Ophthalmology.2023;Volume 17(1)53
[DOI]
5Current management strategy of polypoidal choroidal vasculopathy
ChristineP S Ho,TimothyY Y Lai
Indian Journal of Ophthalmology.2018;66(12)1727
[DOI]
6To compare the short-term efficacy and safety of combination therapy with standard fluence and reduced fluence PDT in polypoidal choroidal vasculopathy
Sameer Iqbal,Sameer Manoj S,Narendra Meel,Unnikrishnan Nair
Indian Journal of Clinical and Experimental Ophthalmology.2022;8(4)520
[DOI]
7Prognostic factors for combined ranibizumab and prompt verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
Yun Hsia,Li-Wei Chan,Chang-Hao Yang,Chung-May Yang,Yi-Ting Hsieh
Photodiagnosis and Photodynamic Therapy.2019;27(4)227
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal